Clinical Trial Update: Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiotherapy with sequential chemotherapy plus a PD-1 inhibitor and thymalfasin for borderline resectable pancreatic ductal ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• PD-1 inhibitor
• Thymalfasin (thymosin alpha-1) (thymosin alpha-1)

Snippet

Sponsor: Ruijin Hospital | Conditions: Carcinoma, Pancreatic Ductal | Phase 2 | Status: NOT_YET_RECRUITING